MRGN: new classification for multidrug-resistant Gram-negative bacteria

被引:0
作者
Kaase, Martin [1 ]
机构
[1] Ruhr Univ Bochum, Dept Med Microbiol, D-44801 Bochum, Germany
来源
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE | 2013年 / 37卷 / 06期
关键词
carbapenemases; Gram-negative bacteria; infection control; MRGN classification; multidrug-resistance; ANTIMICROBIAL SUSCEPTIBILITY; ESCHERICHIA-COLI; CARBAPENEMASES;
D O I
10.1515/labmed-2012-0067
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
New recommendations for infection control in the case of infection or colonization by multidrug-resistant Gram-negative bacteria were published by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch-Institute, Germany. In this context, a new definition for multidrug-resistance, the so-called MRGN classification, was introduced. This was necessary because previous definitions did not seem suitable for the purpose of hospital hygiene. The MRGN classification grades multidrug-resistance by severity distinguishing 3MRGN and 4MRGN, resulting in different recommendations for infection control. In addition, not all antibiotics are regarded equally important in the classification, but only most relevant classes, such as ureidopenicillins, extended-spectrum cephalosporins, carbapenems, and fluoroquinolones, are taken into account. The MRGN classification is mainly based on resistance categories, not on resistance mechanisms. An exception has been made for carbapenemase-producing Enterobacteriaceae, which are always classified as 4MRGN irrespective of their antibiogram due to their importance. The correct MRGN classification should only be performed by experienced microbiological laboratories and requires a reliable detection of carbapenemases.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 7 条
[1]  
[Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5
[2]   Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections [J].
Ben-David, D. ;
Kordevani, R. ;
Keller, N. ;
Tal, I. ;
Marzel, A. ;
Gal-Mor, O. ;
Maor, Y. ;
Rahav, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (01) :54-60
[3]   Carbapenemases in gram-negative bacteria. Current data and trends of resistance resulting from the work of national reference centres [J].
Kaase, M. .
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2012, 55 (11-12) :1401-1404
[4]   Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance [J].
Magiorakos, A. -P. ;
Srinivasan, A. ;
Carey, R. B. ;
Carmeli, Y. ;
Falagas, M. E. ;
Giske, C. G. ;
Harbarth, S. ;
Hindler, J. F. ;
Kahlmeter, G. ;
Olsson-Liljequist, B. ;
Paterson, D. L. ;
Rice, L. B. ;
Stelling, J. ;
Struelens, M. J. ;
Vatopoulos, A. ;
Weber, J. T. ;
Monnet, D. L. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (03) :268-281
[5]   Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli:: failure of automated systems to detect resistance to piperacillin/tazobactam [J].
Pitout, Johann D. D. ;
Le, Phillip ;
Church, Deirdre L. ;
Gregson, Daniel B. ;
Laupland, Kevin B. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (04) :333-338
[6]   Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae [J].
Titelman, Emilia ;
Iversen, Aina ;
Kahlmeter, Gunnar ;
Giske, Christian G. .
APMIS, 2011, 119 (12) :853-863
[7]   Emerging carbapenemases: a global perspective [J].
Walsh, Timothy R. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 :S8-S14